Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-11-047905
Filing Date
2011-09-14
Accepted
2011-09-14 18:27:21
Documents
1
Period of Report
2011-09-13

Document Format Files

Seq Description Document Type Size
1 MAIN DOCUMENT DESCRIPTION c22468_4x0.html 4  
1 MAIN DOCUMENT DESCRIPTION c22468_4x0.xml 4 4636
  Complete submission text file 0001209191-11-047905.txt   6274
Mailing Address 200 CONNELL DRIVE SUITE 1500 BERKELEY HEIGHTS NJ 07922
Business Address 200 CONNELL DRIVE SUITE 1500 BERKELEY HEIGHTS NJ 07922 908-517-7330
Cyclacel Pharmaceuticals, Inc. (Issuer) CIK: 0001130166 (see all company filings)

EIN.: 911766850 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O CYCLACEL PHARMACEUTICALS, INC. 200 CONNELL DRIVE, SUITE 1500 BERKELEY HEIGHTS NJ 07922
Business Address
Rombotis Spiro George (Reporting) CIK: 0001357396 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-50626 | Film No.: 111091396